RESEARCH-USE BIOSIMILAR ANTIBODY

Lemzoparlimab

Monoclonal antibody · IgG4

IAPIgG4RUO

Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity.

TARGETIAP
YMonoclonal antibody
CATALOGSC-BS-437
CATALOG NUMBERSC-BS-437
MOLECULAR WEIGHTApprox. 145.58 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity.

Lemzoparlimab is a recombinant research-use antibody directed against IAP.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Lemzoparlimab | StellaCyte